
    
      OBJECTIVES:

        1. Observe the biomarkers of resectable hepatobiliary tumor recurrence (DFS) and survival
           (OS);

        2. Observe the evolution of tumors and discover specific diagnostic markers as a control
           group.

        3. Observe the response (ORR), progression (PFS) and survival (OS) biomarkers of targeted
           immunotherapy for advanced hepatobiliary tumors;

        4. To elaborate on the multi-omics study of hepatobiliary tumors, to further subtype and
           find therapeutic targets
    
  